Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

No 1 (2014)

Articles

Chronic kidney disease and the aging population

Tonelli M., Riella M.

Abstract

The proportion of older people in the general population is steadily increasing worldwide, with the most rapid growth in low- and middle-income countries [і]. This demographic change is to be celebrated, because it is the consequence of socioeconomic development and better life expectancy. However, population aging also has important implications for society - in diverse areas including health systems, labor markets, public policy, social programs, and family dynamics [2]. A successful response to the aging population will require capitalizing on the opportunities that this transition offers, as well as effectively addressing its challenges. Chronic kidney disease (CKD) is an important public health problem that is characterized by poor health outcomes and very high health care costs. CKd is a major risk multiplier in patients with diabetes, hypertension, heart disease and stroke - all of which are key causes of death and disability in older people [З]. Since the prevalence of CKD is higher in older people, the health impact of population aging will depend in part on how the kidney community responds. March із, 2014 will mark the celebration of the 9 th World Kidney Day (WKD), an annual event jointly sponsored by the International Society of Nephrology and the International Federation of Kidney Foundations. Since its inception in ZOOS, WKD has become the most successful effort to raise awareness among policymakers and the general public about the importance of kidney disease. The topic for WKd 2014 is “CKD in older people”. This article reviews the key links between kidney function, age, health and illness - and discusses the implications of the aging population for the care of people with CKD.
Clinical nephrology. 2014;(1):4-7
pages 4-7 views

Calcium-containing phosphatebinders

- -.
Clinical nephrology. 2014;(1):8-9
pages 8-9 views

Diagnostic significance of biomarkers detection in blood and urine of patients with systemic lupus erythematosus

Rebrov A.P., Zakharova N.B., Oksen'chuk A.N., Karpova O.G., Patrikeeva D.A., Popikhalova E.B.

Abstract

Aim. Study of change of dynamics of levels of biomarkers in blood seruma and urine in patients with systemic lupus erythematosus (SLE). Methods. 40 patients with SLE were included into the study. Levels of interleukins, tumor necrosis factor-alpha (TNF-α), monocyte chemotaxic protein type I (МСР-і), vessel-endothelial growth factor (VEGF) in blood serum and urine were determined by immunoenzyme analysis. Кesults. Levels of VEGF, МСР-і, interleukin-6 (SL-б) were elevated in blood serum; levels of VEGF, IL-6 and IL-8 -in the urine. Biomarkers blood and urine levels did not differed significantly according to SLE activity. Conclusion. Biomarkers determination in blood and urine can help monitoring of clinical evolution and activity of systemic lupus erythematosus.
Clinical nephrology. 2014;(1):10-14
pages 10-14 views

Stratifikatsiya riska razvitiya khronicheskoy bolezni pochek s pomoshch'yu anketirovaniya

Nagaitseva S.S., Shvetsov M.Y., Gerasimov A.N., D Shalyagin Y.D., Ivanova E.S., Shilov E.M.

Abstract

Aim. Estimation of prevalence of albuminuria (Au) as a marker of chronic kidney disease (CKD) and it's risk factors in general population by use of special surveys. Methods. In 1623 general population members (390 (24,0 %) male, 1233 (76,0 %) female, mean age 46 ± 16 years) dipstick urinalysis was performed; urinary albumin > 30 mg/l was considered as Au. Risk factors of CKd were revealed by special survey. Results. AU was found in > 40 % of patients, who applied to Health Centers. According to survey analysis results, the main complaints were peripheral oedema, chest pain, thirst, lack of appetite. 51 % of patients with arterial hypertension had Au. Diabetes or hyperglycemia history was associated with 65,5 % prevalence of Au. AU was found in 44 % overweight patients and in 49 % of patients with obesity. AU was found significantly more often in patients with analgesic abuse, with long history of smoking and in those with low physical activity. Conclusion. Risk of chronic kidney disease in general population can be estimated according to special surveys.
Clinical nephrology. 2014;(1):15-23
pages 15-23 views

Prevalence of type 2 diabetes mellitus in patients with chronic kidney disease in nizhnii novgorog region

Yarkova Ν.A., Borovkov N.N., Solov’ianova E.N., Filina L.V.

Abstract

Aim. Assessment of prevalence of diabetes mellitus (DM) type 2 in patients with chronic kidney disease (CKD) in Nizhnii Novgorod region. Methods. 1051 CKD patients, consulted in Regional clinical hospital and City of Nizhnii Novgorod center of nephrology in 2008-20і3, were included into the study. Results of clinical and laboratory investigation were submitted into the Nizhnii Novgorod CKD registry. Results. dm type 2 is і5,6 % among all the causes of CKD in Nizhnii Novgorod region. 72 % of all patients with dm had CKd stage 2. Microalbuminuria was found mostly often after 5 years, proteinuria - after 10 years after dm manifestation. Conclusion. Diabetes mellitus type 2 is one of the leading causes of chronic kidney disease in Nizhnii Novgorog region
Clinical nephrology. 2014;(1):24-27
pages 24-27 views

INSTRUKTsIYa DLYa AVTOROV ZhURNALA «KLINIChESKAYa NEFROLOGIYa»

- -.
Clinical nephrology. 2014;(1):27-27
pages 27-27 views

Development of diagnosis of specific and non-specific lesions of upper urinary tract

Zuban’ O.N., Ckorniakov C.N., Novikov B.I., Borodin E.P., Arkanov L.V.

Abstract

Aim. Improvement of tuberculous ureteritis by use of ureteroscopy as part of clinical diagnostic protocol. Methods. Clinical course of urinary tract involvment was studied in 112 patients with urinary tuberculosis and 74 - with uretheral strictures of non-tuberculous etiology, hospitalized during 2006-2011. Patients were divided into 2 groups: 1st - 48 (25,8 %) patients with nephrotubersulosis without uretheral involvement, 2nd - 64 (34,4 %) patients with renal tuberculosis with ureteral involvement, 3rd - 74 (39,8 %) patients with ureteral strictures of non-tuberculous genesis. Results. Patients with renal tuberculosis with ureteral involvement were characterized by maximal prevalence of organ destruction, chronic renal failure, and spreading to urinary bladder and paravesical cellular tissue. Chronic renal failure in patients with renal tuberculosis was more severe, than in those, who had ureteral stricture of non-tuberculous etiology. Conclusion. Renal tuberculosis with urinary tract involvement is characterized by most severe ureteral lesion, which can be revealed by ureteropyeloscopy with multifocal ureteral biopsy.
Clinical nephrology. 2014;(1):28-32
pages 28-32 views

Bone mineral density, bone and phosphate-calcium metabolism parameters in patients with oxalate nephropathy in early stages of chronic kidney disease

Voronina N.V., Agievich T.B.

Abstract

Aim. Estimation of bone mineral density by densitometry in correlation with bone metabolism and calcium-phosphorus metabolism parameters in young patients with oxalate nephropathy and chronic kidney disease (CKD) 1-2 stage. Methods. 102 patients with oxalate nephropathy and CKD 1-2 stage (age і8-40 years) were included into the study. X-Ray absorbtiometry (Dxa) was used for bone mineral density (BMD) measurement. Serum levels of osteocalcine, terminal C-peptide (β-CrossLaps), parathyreoid hormone (PTH), 25 hydroxyvitamine D D[25(0H)D3], concentrations of calcium, phosphate, activity of alkaline phosphatase, creatinine were determined; glomerular filtration rate was calculated by Cockroft-Gault. Results. Densitometry revealed decrease of bone mineral density in patients with oxalate nephropathy and CKD 1-2 stage. Bmd decrease was associated with lowering of serum level of total calcium, elevation of total alkaline activity, PTh, osteocalcine and β-Cross Laps. Serum levels of 25(0H)D3 and phosphate did not differ significantly from healthy controls. Conclusion. Patients with oxalate nephropathy and chronic kidney disease 1-2 stage have osteopenia, which requires therapeutic correction.
Clinical nephrology. 2014;(1):33-35
pages 33-35 views

Unresolver problem of calcium in phosphate-binding therapy of bone-mineral metabolism dis-turbances in patients with chronic kidney disease on program hemodialysis

Khoroshilov S.E.

Abstract

Risk factors and pathogenesis of vascular calcification in chronic kidney disease are discussed. Therapeutic approaches to correction of bone-mineral metabolism disturbances in chronic kidney disease are reviewed with special attention to comparison of different phosphate-binders.
Clinical nephrology. 2014;(1):36-41
pages 36-41 views

Therapy of ANCA-associated systemic vasculitides: current approaches

Novikov P.I., Moisseev S.V., Bulanov N.M., Makarov E.A.

Abstract

Modern therapeutic approaches to treatment of ANCA-associated systemic vasculitides and algoritms of treatment choice are presented. Controlled clinical trials in patients with ANCA-associated systemic vasculitides are discussed. Role of target biological therapy of systemic vasculitides is reviewed.
Clinical nephrology. 2014;(1):42-49
pages 42-49 views

Proteomic spectrum of the urine in nephropathy of different genesis

Batiushin M.M., Bronovitskaya N.A., Gassanov M.Z., Sarvilin I.V.

Abstract

Results of original investigations in renal urinary proteomics are discussed. Proteomic urinary patterns in primary and paraneoplastic glomerulonephritis and their dynamics in tubulo-interstitial fibrosis are shown. Perspectives of urinary proteomics study in development of new non-invasive diagnostic technologies are shown.
Clinical nephrology. 2014;(1):50-54
pages 50-54 views

Therapeutic tactics in tertiary hyperparathyroidism after renal transplantation (Review and clinical observations)

Vetchinnikova O.N., Kantariya R.O.

Abstract

Literature review and clinical case of patients with hyperparathyroidism after renal transplantation are presented. Clinical features, bone-mineral disorders, diagnostic and treatment (surgical treatment and cinacalcet use) algorithms in tertiary hyperparathyroidism are discussed.
Clinical nephrology. 2014;(1):55-63
pages 55-63 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies